Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Aptiom (eslicarbazepine) and Trileptal (oxcarbazepine) are both antiepileptic medications used to treat partial-onset seizures. Both Aptiom and Trileptal are available in both brand-name and generic forms. Aptiom is typically taken once daily, whereas Trileptal can be taken once or twice daily depending on the formulation. Both medications can cause dizziness, headaches, and low sodium levels, but Aptiom can also cause sleepiness and vision problems. Trileptal, on the other hand, has a higher risk of causing severe skin reactions, especially in people of Asian descent. Additionally, Trileptal is available in an oral liquid form, which can be helpful for those who have trouble swallowing tablets. Both medications can interact with other drugs and may require regular blood tests to monitor sodium levels.
Aptiom (eslicarbazepine)
Oxcarbazepine (Trileptal)
Aptiom (eslicarbazepine)
Oxcarbazepine (Trileptal)
Summary of Aptiom vs. Trileptal
Summary for Antiepileptic
Prescription only
Aptiom (eslicarbazepine) helps control seizures if you have partial-onset epilepsy. It can be used in people aged 4 years and older, but it interacts with some other medications and can be expensive if not covered by insurance.
Summary for Antiepileptic
Prescription only
Oxcarbazepine (Trileptal) is used to treat partial-onset seizures (also called focal aware seizures). This antiepileptic is for people 2 years of age and older. It helps calm the brain to keep seizures from happening. Oxcarbazepine (Trileptal) comes as immediate-release tablets and an oral suspension. You take it by mouth twice a day. Some common side effects include dizziness, nausea, and headaches. Immediate-release oxcarbazepine comes in both brand-name and generic versions. You can take it by itself or with other anti-seizure medications.